Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05172700
Title Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Loxo Oncology, Inc.
Indications

mantle cell lymphoma

Waldenstroem's macroglobulinemia

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

LOXO-305

Age Groups: adult | senior
Covered Countries


No variant requirements are available.